Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells:: preclinical and first clinical results of a phase I/II clinical trial

被引：0
|
作者：
Ocadlikova, D.
Zahradova, L.
Kovarova, L.
Smejkalova, J.
Pour, L.
Vidlakova, P.
Kyjovska, D.
Stejskalova, A.
Novotna, H.
Penka, M.
Michalek, J.
Hajek, R.
机构：
[1] Masaryk Univ, Cell Immunotherapy Ctr, Brno, Czech Republic
[2] Univ Hosp, Dept Hematooncol, Brno, Czech Republic
[3] Univ Hosp, Dept Pediat 1, Brno, Czech Republic
[4] Univ Hosp, Dept Clin Hematol, Brno, Czech Republic
[5] Univ Hosp, Dept Clin Biochem, Brno, Czech Republic
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70213-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [41] Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial
    Lichtenegger, Felix S.
    Schnorfeil, Frauke M.
    Koehnke, Thomas
    Altmann, Torben
    Buecklein, Veit
    Moosmann, Andreas
    Brueggemann, Monika
    Wagner, Beate
    Hiddemann, Wolfgang
    Bigalke, Iris
    Kvalheim, Gunnar
    Subklewe, Marion
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [42] Clinical results of a Phase I/II trial of adjuvant therapeutic vaccination in high risk resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue, hTERT and survivin
    Tryggestad, Anne Merete Aa.
    Axcrona, Karol
    Bigalke, Iris
    Inderberg-Suso, Else M.
    Skorstad, Gjertrud
    Axcrona, Ulrika
    Aamdal, Steinar
    Gaudernack, Gustav
    Schendel, Dolores
    Lilleby, Wolfgang
    Dueland, Svein
    Kvalheim, Gunnar
    CANCER RESEARCH, 2016, 76
  • [43] Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
    Bernard Escudier
    Thierry Dorval
    Nathalie Chaput
    Fabrice André
    Marie-Pierre Caby
    Sophie Novault
    Caroline Flament
    Christophe Leboulaire
    Christophe Borg
    Sebastian Amigorena
    Catherine Boccaccio
    Christian Bonnerot
    Olivier Dhellin
    Mojgan Movassagh
    Sophie Piperno
    Caroline Robert
    Vincent Serra
    Nancy Valente
    Jean-Bernard Le Pecq
    Alain Spatz
    Olivier Lantz
    Thomas Tursz
    Eric Angevin
    Laurence Zitvogel
    Journal of Translational Medicine, 3
  • [44] Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
    Escudier, B
    Dorval, T
    Chaput, N
    André, F
    Caby, MP
    Novault, S
    Flament, C
    Leboulaire, C
    Borg, C
    Amigorena, S
    Boccaccio, C
    Bonnerot, C
    Dhellin, O
    Movassagh, M
    Piperno, S
    Robert, C
    Serra, V
    Valente, N
    Le Pecq, JB
    Spatz, A
    Lantz, O
    Tursz, T
    Angevin, E
    Zitvogel, L
    JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
  • [45] Bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma: results of a phase I/II clinical trial
    Popat, R.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singeri, C.
    Gurnbleton, T.
    Foot, N.
    Oakervee, H.
    Cavenagh, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 60 - 61
  • [46] Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
    Trepiakas, Redas
    Berntsen, Annika
    Hadrup, Sine Reker
    Bjorn, Jon
    Geertsen, Poul F.
    Straten, Per Thor
    Andersen, Mads H.
    Pedersen, Anders E.
    Soleimani, Amir
    Lorentzen, Torben
    Johansen, Julia S.
    Svane, Inge Marie
    CYTOTHERAPY, 2010, 12 (06) : 721 - 734
  • [47] Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial
    Koeneman, Bouke J.
    Schreibelt, Gerty
    Gorris, Mark A. J.
    Hins-de Bree, Simone
    Westdorp, Harm
    Ottevanger, Petronella B.
    de Vries, I. Jolanda M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Dendritic-cell based immunotherapy for HIV is safe and immunogenic: results of a phase I/II clinical trial
    de Goede, A. L.
    de Keersmaecker, B.
    Allard, S. D.
    van der Ende, I. E.
    Lacor, P.
    van Baalen, C. A.
    Thielemans, K.
    Osterhaus, A. D.
    Gruters, R. A.
    Aerts, J. L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A89 - A90
  • [49] DENDRITIC CELL THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM): FINAL RESULTS OF A PHASE I/II CLINICAL TRIAL
    Saevels, K.
    Anguille, S.
    Van de Velde, A.
    Snoeckx, A.
    Van Meerbeeck, J.
    Van den Wijngaert, T.
    Lion, E.
    Stein, B.
    Nijs, G.
    Huizing, M.
    Van Tendeloo, V.
    Germonpre, P.
    Smits, E.
    Berneman, Z.
    HAEMATOLOGICA, 2016, 101 : 121 - 121
  • [50] Treatment of hormone refractory prostate cancer patients by vaccination with autologous dendritic cells pulsed with recombinant prostate specific membrane antigen: A Phase I/II clinical trial
    Elgamal, AAA
    Boynton, A
    Bosch, M
    Salgaller, M
    Lodge, PA
    Shankar, G
    Belldegrun, A
    Logothetis, C
    Papandreou, C
    JOURNAL OF UROLOGY, 2002, 167 (04): : 306 - 306
12345